Liên Minh Châu Âu - Tiếng Séc - EMA (European Medicines Agency)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimykotika pro systémové použití - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.

Cộng hòa Séc - Tiếng Séc - SUKL (Státní ústav pro kontrolu léčiv)

wörwag pharma gmbh & co. kg, böblingen array - 138 benfotiamin; 15177 triturace kyanokobalaminu s laktosou 0.5 % - obalená tableta - 50mg/250mcg - vitamin b1 v kombinaci s vitaminem b6 a/nebo b12

Liên Minh Châu Âu - Tiếng Séc - EMA (European Medicines Agency)

otsuka novel products gmbh - delamanid - tuberkulóza, multirezistentní - antimykobakteriální látky - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 a 5. pozornost by měla být věnována oficiálním doporučením pro správné používání antibakteriálních látek.

Liên Minh Châu Âu - Tiếng Séc - EMA (European Medicines Agency)

merck sharp & dohme b.v. - elbasvir, grazoprevir - hepatitida c, chronická - direct acting antivirals, antivirals for systemic use, antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 a 5. pro virus hepatitidy c (hcv) genotypu-konkrétní aktivity viz bod 4. 4 a 5.

Liên Minh Châu Âu - Tiếng Séc - EMA (European Medicines Agency)

glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - imunitní séra a imunoglobuliny, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.

Liên Minh Châu Âu - Tiếng Séc - EMA (European Medicines Agency)

merck sharp & dohme b.v. - sugammadex - neuromuskulární blokáda - všechny ostatní terapeutické přípravky - zvrat neuromuskulární blokády vyvolané rocuroniem nebo vekuroniem. pro peadiatric populace: sugammadex je doporučen pouze pro běžné zrušení rokuronia vyvolané blokády u dětí a dospívajících.

Liên Minh Châu Âu - Tiếng Séc - EMA (European Medicines Agency)

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Liên Minh Châu Âu - Tiếng Séc - EMA (European Medicines Agency)

roche registration gmbh - polatuzumab vedotin - lymfom b-buněk - antineoplastická činidla - polivy v kombinaci s bendamustin a rituximab je indikován pro léčbu dospělých pacientů s relabující/refrakterní difuzní velkobuněčný b-lymfom (dlbcl), kteří nejsou kandidáty pro transplantaci hematopoetických kmenových buněk. polivy in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone (r-chp) is indicated for the treatment of adult patients with previously untreated diffuse large b-cell lymphoma (dlbcl).

Liên Minh Châu Âu - Tiếng Séc - EMA (European Medicines Agency)

astrazeneca ab - tezepelumab - astma - léky na obstrukční onemocnění dýchacích cest, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.

Cộng hòa Séc - Tiếng Séc - SUKL (Státní ústav pro kontrolu léčiv)

viatris healthcare limited, dublin array - 4352 fenofibrÁt - potahovaná tableta - 215mg - fenofibrÁt